4//SEC Filing
Sullivan Timothy Eugene 4
Accession 0001127602-25-001627
CIK 0001492422other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:11 PM ET
Size
7.4 KB
Accession
0001127602-25-001627
Insider Transaction Report
Form 4
Sullivan Timothy Eugene
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-17$29.96/sh−1,730$51,828→ 86,370 total - Award
Common Stock
2025-01-21+45,929→ 132,299 total
Holdings
- 70,396(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
- [F3]The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001707000
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:11 PM ET
- Size
- 7.4 KB